Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03708263Not ApplicableTerminated

Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea

Role: collaborator

NCT01742702Unknown

HaemoDYNAMICs in Primary and Secondary Hypertension

Role: collaborator

NCT00524446Phase 3Completed

Controlled Trial to Test the Efficacy of Lipid-based Nutrient Supplements to Prevent Severe Stunting Among Infants

Role: collaborator

NCT01348646Not ApplicableCompleted

Adult Follow-up of Preventive Study With Brief Smoking Intervention for Adolescents

Role: collaborator

All 4 trials loaded